Literature DB >> 7629117

Probing the "message:address" sites for chemoattractant binding to the C5a receptor. Mutagenesis of hydrophilic and proline residues within the transmembrane segments.

L F Kolakowski1, B Lu, C Gerard, N P Gerard.   

Abstract

The C5a anaphylatoxin ligand-receptor interaction on polymorphonuclear granulocytes stimulates chemotaxis, degranulation, and the oxidative burst. The receptor is a member of the large G-protein-coupled family. The ligand is a cationic peptide of 72 amino acids derived from the C5 component of complement and has been shown to have a number of structural requirements for interaction with the receptor. In order to probe the potential interaction sites between ligand and receptor, we constructed a series of mutated receptor molecules, targeting cysteines, prolines, and additional amino acids of interest because of combinations of charge or hydrophobicity and putative location with respect to the membrane. Transfected mutant receptors were analyzed for cell surface expression, ligand binding, and ligand-activated phospholipase C activity. The receptors created can be placed generally in four distinct classes: those which bind and signal like the natural receptor; those which bind but fail to transduce signals; those which are expressed but neither bind nor transduce signal; and those which are not expressed at the cell surface.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7629117     DOI: 10.1074/jbc.270.30.18077

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

Review 1.  The role of the anaphylatoxins in health and disease.

Authors:  Andreas Klos; Andrea J Tenner; Kay-Ole Johswich; Rahasson R Ager; Edimara S Reis; Jörg Köhl
Journal:  Mol Immunol       Date:  2009-05-28       Impact factor: 4.407

2.  Identification of receptor-binding sites of monocyte chemotactic S19 ribosomal protein dimer.

Authors:  Y Shibuya; M Shiokawa; H Nishiura; T Nishimura; N Nishino; H Okabe; K Takagi; T Yamamoto
Journal:  Am J Pathol       Date:  2001-12       Impact factor: 4.307

3.  Dissecting the functions of conserved prolines within transmembrane helices of the D2 dopamine receptor.

Authors:  Ethan B Van Arnam; Henry A Lester; Dennis A Dougherty
Journal:  ACS Chem Biol       Date:  2011-07-28       Impact factor: 5.100

4.  GPCR-I-TASSER: A Hybrid Approach to G Protein-Coupled Receptor Structure Modeling and the Application to the Human Genome.

Authors:  Jian Zhang; Jianyi Yang; Richard Jang; Yang Zhang
Journal:  Structure       Date:  2015-07-16       Impact factor: 5.006

5.  Mechanisms governing the activation and trafficking of yeast G protein-coupled receptors.

Authors:  C J Stefan; M C Overton; K J Blumer
Journal:  Mol Biol Cell       Date:  1998-04       Impact factor: 4.138

6.  Third extracellular loop (EC3)-N terminus interaction is important for seven-transmembrane domain receptor function: implications for an activation microswitch region.

Authors:  Soumendra Rana; Thomas J Baranski
Journal:  J Biol Chem       Date:  2010-07-27       Impact factor: 5.157

7.  Molecular analysis of the bovine anaphylatoxin C5a receptor.

Authors:  Sailasree Nemali; Daniel W Siemsen; Laura K Nelson; Peggy L Bunger; Craig L Faulkner; Pascal Rainard; Katherine A Gauss; Mark A Jutila; Mark T Quinn
Journal:  J Leukoc Biol       Date:  2008-05-14       Impact factor: 4.962

8.  New insights into human prostacyclin receptor structure and function through natural and synthetic mutations of transmembrane charged residues.

Authors:  J Stitham; E Arehart; S R Gleim; N Li; K Douville; J Hwa
Journal:  Br J Pharmacol       Date:  2007-08-20       Impact factor: 8.739

9.  Molecular cloning and characterization of rainbow trout (Oncorhynchus mykiss) C5a anaphylatoxin receptor.

Authors:  Kazuhiro Fujiki; Lei Liu; Roy S Sundick; Brian Dixon
Journal:  Immunogenetics       Date:  2003-11-20       Impact factor: 2.846

Review 10.  Function, structure and therapeutic potential of complement C5a receptors.

Authors:  P N Monk; A-M Scola; P Madala; D P Fairlie
Journal:  Br J Pharmacol       Date:  2007-07-02       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.